BioVie Inc., a Nevada corporation, has announced a special meeting of stockholders to be held virtually on July 29, 2024. The meeting will address two key proposals: the authority for a reverse stock split of the company's common stock at a ratio between 1-for-6 and 1-for-10, and the discretionary authority to adjourn the meeting if necessary to solicit additional proxies if there are insufficient votes to approve the reverse stock split. The Board of Directors has recommended voting in favor of both proposals. Stockholders as of the record date, June 13, 2024, are entitled to vote and have been provided with instructions on how to participate in the virtual meeting. The reverse stock split aims to increase the per-share trading price of...Show More

BioVie Inc., a Nevada corporation, has announced a special meeting of stockholders to be held virtually on July 29, 2024. The meeting will address two key proposals: the authority for a reverse stock split of the company's common stock at a ratio between 1-for-6 and 1-for-10, and the discretionary authority to adjourn the meeting if necessary to solicit additional proxies if there are insufficient votes to approve the reverse stock split. The Board of Directors has recommended voting in favor of both proposals. Stockholders as of the record date, June 13, 2024, are entitled to vote and have been provided with instructions on how to participate in the virtual meeting. The reverse stock split aims to increase the per-share trading price of BioVie's common stock to comply with Nasdaq's minimum bid price requirement and to make the stock more appealing to investors. The company's common stock is currently quoted on Nasdaq under the ticker symbol BIVI. The Board of Directors will determine the exact ratio for the reverse stock split if the proposal is approved by stockholders. The reverse stock split is not intended to reduce the number of authorized shares of common stock or preferred stock, nor will it affect the par values of these stocks.